Exact Mass: 494.1154
Exact Mass Matches: 494.1154
Found 172 metabolites which its exact mass value is equals to given mass value 494.1154
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Salvianolic acid A
Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation. Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.
Quercetagetin 3'-methylether 7-glucoside
Quercetagetin 3-methylether 7-glucoside is found in garland chrysanthemum. Quercetagetin 3-methylether 7-glucoside is isolated from Chrysanthemum coronarium (chop-suey greens). Isolated from Chrysanthemum coronarium (chop-suey greens). Quercetagetin 3-methylether 7-glucoside is found in garland chrysanthemum and herbs and spices.
Phenolphthalein glucuronide
Salvianolic acid A
Patuletin 7-glucoside
Patuletin 7-glucoside is a member of the class of compounds known as flavonoid-7-o-glycosides. Flavonoid-7-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. Patuletin 7-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Patuletin 7-glucoside can be found in german camomile, which makes patuletin 7-glucoside a potential biomarker for the consumption of this food product.
Salvianolic
Salvianolic acid A is a stilbenoid. Salvianolic acid A is under investigation in clinical trial NCT03908242 (Phase I Study of Continuous Administration of Salvianolic Acid A Tablet). Salvianolic acid A is a natural product found in Salvia miltiorrhiza, Salvia flava, and other organisms with data available. D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors D000970 - Antineoplastic Agents Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation. Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.
3,5,7,3,4-Pentahydroxy-6,8-dimethoxyflavone 3-alpha-L-arabinopyranoside
Quercetagetin 7-methyl ether 4-glucoside
Myricetin 4-methyl ether 3-O-beta-D-galactopyranoside
Quercetagetin 7-methyl ether 6-glucoside
Quercetagetin 7-methyl ether 3-glucoside
Hibiscetin 8-methyl ether 3-rhamnoside
3-O-(E)-caffeoyl-4-O-galloyl-D-glucopyranose|3-O-(E)-Caffeoyl-4-O-galloyl-??-D-glucopyranose
3,5-Di-Me ether,tri-Ac-3,4,4,5,5-Pentahydroxy-2,7-cycloligna-7,7-dien-9,9-olide
Me glycoside,4,6-dibenzoyl,2-mesyl-3-O-Methylgalactose
1-O-(E)-caffeoyl-3-galloyl-beta-D-glucopyranose|1-O-(E)-caffeoyl-3-O-galloyl-beta-D-glucopyranose|1-O-(E)-Caffeoyl-3-O-galloyl-??-D-glucopyranose
1-O-caffeoyl-6-O-galloyl-beta-D-glucopyranose|1-O-(E)-caffeoyl-6-O-galloyl-beta-D-glucopyranose
11-O-(3-O-methylgalloyl)-bergenin|11-O-(3-O-methylgalloyl)bergenin
12,13-dihydro-3,4,5,7-tetrahydroxy-12-hydroxymethyl-13-(17-hydroxyl-16,18-dimethoxyphenyl)-7H-benzo[c]xanthen-4-one|falloconvolin B
3,4,5,6,8,13-Hexahydro-2-methyl-8,13-dioxo-2,6-epoxy-2H-anthra[2,3-b]oxocin-7,9,11-triyl=triacetate
5-O-beta-D-glucopyranosyl-6-[(1E,3E)-6-hydroxy-1,3-hexadienyl]-2-hydroxymethyl-thieno[2,3-e]isobenzofuran-8(6H)-one|echinothiophene
Laricitrin 3-O-glucoside
Laricitrin 3-O-glucoside is a natural product found in Vitis vinifera and Picea abies with data available.
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-8-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Quercetagetin 3'-methylether 7-glucoside
DICHLOROBIS[2-(DI-I-PROPYLPHOSPHINO)ETHYLAMINE]RUTHENIUM (II), MIN
1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea
2,6-Dichloro-4-(2-Piperazin-1-Ylpyridin-4-Yl)-N-(1,3,5-Trimethyl-1h-Pyrazol-4-Yl)benzenesulfonamide
96574-01-5
D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors D000970 - Antineoplastic Agents Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation. Salvianolic acid A could protect the blood brain barrier through matrix metallopeptidase 9 (MMP-9) inhibition and anti-inflammation.
Patulitrin
4-(4-Acetyloxyphenyl)benzoic acid [2-[[2-(2-chloroanilino)-2-oxoethyl]-methylamino]-2-oxoethyl] ester
4-chloro-N-[(2R,3S,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2S,3R,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2S,3S,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2S,3R,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2S,3S,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2R,3R,6R)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2R,3S,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
4-chloro-N-[(2R,3R,6S)-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]benzenesulfonamide
[(1S)-2-[2-[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-2-carboxyethyl]selanyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium
2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-8-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
ALDH1A1-IN-2
ALDH1A1-IN-2 is a potent inhibitor of aldehyde dehydrogenase 1a1 (aldh1a1). Aldehyde dehydrogenases (ALDH) constitute a family of enzymes that play a critical role in oxidizing various cytotoxic xenogenic and biogenic aldehydes. ALDH1A1-IN-2 has the potential for the research of cancer, inflammation, or obesity (extracted from patent WO2019089626A1, compound 295)[1].
Uplarafenib
Uplarafenib (B-Raf IN 10) (Compound C09) is a BRAF inhibitor with an IC50 between 50 and 100 nM. Uplarafenib shows antitumor activity[1].
5,7-dihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one
5,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl}prop-2-enoyl]oxy}propanoic acid
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-3-methoxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
(2s,3r,4s,5r,6r)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl 3,4,5-trihydroxybenzoate
2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-3-{[(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
1-o-(e)-caffeoyl-3-o-galloyl-β-d-glucopyra-nose
{"Ingredient_id": "HBIN002898","Ingredient_name": "1-o-(e)-caffeoyl-3-o-galloyl-\u03b2-d-glucopyra-nose","Alias": "NA","Ingredient_formula": "C22H22O13","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OC2C(C(C(C(O2)CO)O)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2902","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-(e)-caffeoyl-4-o-galloyl-β-d-glucopyra-nose
{"Ingredient_id": "HBIN009316","Ingredient_name": "3-o-(e)-caffeoyl-4-o-galloyl-\u03b2-d-glucopyra-nose","Alias": "NA","Ingredient_formula": "C22H22O13","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OC2C(C(OC(C2OC(=O)C3=CC(=C(C(=C3)O)O)O)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2903","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7,3',4'-tetrahydroxy-8-methoxyflavonol-3-o-beta-d-galactoside
{"Ingredient_id": "HBIN011189","Ingredient_name": "5,7,3',4'-tetrahydroxy-8-methoxyflavonol-3-o-beta-d-galactoside","Alias": "5,7,3',4'-tetrahydroxy-8-methoxyflavonol-3-o-\u03b2-d-galactoside","Ingredient_formula": "C22H22O13","Ingredient_Smile": "COC1=C(C=C(C2=C1OC(=C(C2=O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "32038;21111","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}